BIO CEO & Investor Conference is one of the largest investor conferences in the Life Sciences industry where institutional investors, industry analysts and senior executives are shaping the future investment landscape of biotechnology. Hear from thought-leaders during sessions on therapeutic advancements, market outlook and policy priorities, and discover the latest innovations in biotech.
Partner Joe Conahan will be moderating the “Market Outlook: Deal-Making and M&A for 2025” panel that discusses how a new US administration and regulatory uncertainty will impact M&A trends, as well as how smaller companies should plan their capital access options for 2025.